基于栖息亚区域的多机器学习模型预测子宫动脉栓塞治疗子宫腺肌症的疗效
本研究基于T2WI将子宫腺肌症病灶划分为栖息亚区域并提取影像组学特征,用六种机器学习分类器建立栖息亚区域影像组学模型(HRM),在191例训练队列和67例测试队列中预测子宫动脉栓塞术后36个月症状改善,HRM的AUC分别为0.921和0.890,优于全区域模型和临床模型。
要点
- 基于T2WI的栖息亚区域影像组学模型可预测子宫动脉栓塞治疗子宫腺肌症的长期疗效。
- HRM训练队列AUC 0.921、测试队列AUC 0.890,均高于全区域模型和临床模型。
- ROI经k-means聚类分为4个栖息亚区域,LASSO回归后纳入24个亚区域特征。
核心结论
- HRM能预测子宫动脉栓塞治疗子宫腺肌症的长期疗效,预测性能优于WRM和CM,可作为辅助介入医师临床决策的有效工具。
研究设计与样本
- 研究为预测模型建立与验证研究,训练队列来自机构A于2015年11月至2018年6月接受UAE的子宫腺肌症患者,测试队列来自机构B于2017年6月至2019年6月的患者。
- 共纳入258例患者,训练队列191例,测试队列67例。
- 在T2WI上手动勾画ROI,用k-means聚类将ROI划分为栖息亚区域,从T1WI、T2WI、表观扩散系数和增强图像的每个亚区域提取影像组学特征。
- 用LASSO选择亚区域影像组学特征,以UAE术后36个月患者症状改善为结局,用六种机器学习分类器训练,根据模型性能选择最合适分类器建立HRM。
- 另建立全区域影像组学模型(WRM)和临床模型(CM),用DeLong检验比较HRM与两模型的预测性能。
诊断标准与关键数值
- ROI被划分为4个栖息亚区域,LASSO回归后24个栖息亚区域特征纳入模型。
- HRM的AUC为训练队列0.921(95% CI,0.857-0.985)、测试队列0.890(95% CI,0.736-1.000)。
- WRM的AUC为训练队列0.805(95% CI,0.737-0.872)、测试队列0.693(95% CI,0.497-0.889)。
- CM的AUC为训练队列0.788(95% CI,0.711-0.866)、测试队列0.735(95% CI,0.566-0.903)。
- HRM与WRM预测性能差异有统计学意义(训练队列p=0.008,测试队列p=0.007);HRM与CM在训练队列差异有统计学意义(p=0.014),在测试队列无统计学显著差异(p=0.186)。
临床应用与阅片要点
- 作者认为HRM可作为辅助介入医师临床决策的有效工具,用于预测UAE治疗子宫腺肌症的长期疗效。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To establish and validate a predictive multi-machine learning model for the long-term efficacy of uterine artery embolization (UAE) in the treatment of adenomyosis based on habitat subregions.
MATERIALS AND METHODS: Patients who underwent UAE for adenomyosis at institution A between November 2015 and June 2018 were included in the training cohort and those at institution B between June 2017 and June 2019 were included in the test cohort. The regions of interest (ROI) were manually segmented on the T2-weighted images (T2WI). The ROIs were subsequently partitioned into habitat subregions using k-means clustering. Radiomic features were extracted from each subregion on T1WI, T2WI, apparent diffusion coefficient, and contrast-enhanced images. The least absolute shrinkage and selection operator (LASSO) was used to select the subregion radiomics features. With the improvement in patients' symptoms at 36 months post-UAE, the habitat subregion features were trained using six machine-learning classifiers. The most suitable classifier was chosen based on model performance to establish the habitat radiomics model (HRM). The efficacy of the model was validated using both the training and test cohorts. Finally, a whole-region radiomics model (WRM) and clinical model (CM) were established. The Delong test was used to compare the predictive performance of the habitat subregion model and the two other models.
RESULTS: The study included 258 patients, 191 in the training cohort and 67 in the test cohort. The ROIs were divided into four habitat subregions. Radiomics features were extracted from different sequence images of the subregions. After LASSO regression, 24 habitat subregion features were included in the model. Based on the receiver operating characteristic curve analysis, the area under the curve (AUC) of the HRM was 0.921 (95% CI, 0.857-0.985, training) and 0.890 (95% CI, 0.736-1.000, test). The AUCs for the WRM were 0.805 (95% CI, 0.737-0.872, training) and 0.693 (95% CI, 0.497-0.889, test). Compared to the HRM, the difference in predictive performance was statistically significant (p = 0.008, training; p = 0.007, test). The AUCs for the CM were 0.788 (95% CI, 0.711-0.866, training) and 0.735 (95% CI, 0.566-0.903, test). Compared to the HRM, there was a statistically significant difference in the training cohort (p = 0.014) but not in the test cohort (p = 0.186).
CONCLUSION: The HRM can predict the long-term efficacy of UAE in the treatment of adenomyosis. The predictive performance was superior to that of both the WRM and CM, serving as an effective tool to assist interventional physicians in clinical decision-making.
引用
- Jin W, Wang S, Wang T, et al. Multi-machine Learning Model Based on Habitat Subregions for Outcome Prediction in Adenomyosis Treated by Uterine Artery Embolization. Acad Radiol. 2024. PMID: 38845295. doi:10.1016/j.acra.2024.05.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。